01307 Dresden, de
+49 (351) 796 57 80
Transinsight and antibodies-online develop Software for semantic Gene and Protein Identification
Semantically fitting research antibodies will be automatically suggested within GoPubMed's search results for abstracts from biomedical publications
"The scientist, who keeps himself uptodate on recent biomedical publications with our knowledgebased search engine GoPubMed.com is now further supported by suggestions of semantically fitting research products for his/her specific research needs" says Dr. Michael R. Alvers, founder and CEO of Transinsight GmbH. The time consuming search for the right research antibody to a specific research question is one of the key pains in proteomics and genomics laboratories. Any simplification of this search problem, which delivers correct information instead of unhelpful, generic advertising, is welcome within the scientific community. Searching, finding and ordering the right research antibody from within a global offer of 500.000 products from more than 500 suppliers worldwide is normally a tedious work. To apply semantic, knowledge driven product recommendations to biomedical publications and thus to allow to significantly reduce the workload for the scientist always in need of research products is a truly innovative approach.
"Once the scientist has chosen a product of interest, antibodiesonline GmbH takes care of all the rest, i.e. procurement of the desired products from anywhere around the world", adds Dr. Andreas Kessell, founder and managing director of antibodiesonline GmbH. "Our customer is not bound to the portfolio of a single supplier but can chose from a neutral portfolio of research antibodies, that are suggested with the biomedical publications" says Dr. Kessell.
The software solution behind this innovative offer of the partnering companies Transinsight und antibodiesonline is currently being developed within the THESEUS research program. Transinsight's existing semantic search platform already detects genes and proteins reliably in scientific publications and these results can be linked to the products on antibodiesonline.com. "With the launch of this first prototype we managed the initial integration of the information provided on the two platforms of the partnering companies - however, the list of tasks to be taken on remains long" explains Dr. Alvers.
About antibodies-online GmbH
With more than 200.000 research antibodies offered antibodiesonline GmbH is one of the leading internet marketplaces for research products worldwide. The scientific community apparently searches the internet for products that suit their research needs. On antibodiesonline's websites scientists can search or browse the offer of numerous suppliers worldwide as well as order the antibody directly online, via phone or via fax. The company was founded as a spinoff of Aachen Technology University and the University Hospital of Aachen as a supplier independent German platform in April 2006. By the end of 2008 anticorpsenligne.fr, kangtizaixian.cn and antibodiesonline.com were launched as international marketplaces. Since then all listed antibodies are marketed and distributed worldwide.
About THESEUS research program
The THESEUS research program was launched by the Federal Ministry of Economics and Technology (BMWi) in 2007 as a flagship project of the German Federal Government. As part of the program, about 60 companies, research institutes and universities are running projects to develop applicationorientated basic technologies and technical standards for the internet of services. The aim is to develop new products and services for the internet. The program is scheduled to run for five years and is funded by around €100 m from the BMWi. The funds made available for research and development are being divided equally between science and economics. An additional €100 m is being contributed by interested partners in industry and research from their own funds.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.